These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6151503)

  • 1. The international prospective primary prevention study in hypertension (IPPPSH): objectives and methods. The IPPPSH Collaborative Group.
    Eur J Clin Pharmacol; 1984; 27(4):379-91. PubMed ID: 6151503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group.
    J Hypertens; 1985 Aug; 3(4):379-92. PubMed ID: 2864374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial infarctions and cerebrovascular accidents in relation to blood pressure control. The IPPPSH Collaborative Group.
    J Hypertens Suppl; 1985 Dec; 3(3):S513-8. PubMed ID: 2856779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking, antihypertensive treatment benefit, and comprehensive antihypertensive treatment approach: some thoughts on the results of the International Prospective Primary Prevention Study in Hypertension.
    Bolli P; Bühler FR; McKenzie JK
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S77-80. PubMed ID: 1708033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of smoking on heart attacks, strokes, blood pressure control, drug dose, and quality of life aspects in the International Prospective Primary Prevention Study in Hypertension.
    Bühler FR; Vesanen K; Watters JT; Bolli P
    Am Heart J; 1988 Jan; 115(1 Pt 2):282-8. PubMed ID: 2892388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.
    Hansson L; Lindholm LH; Niskanen L; Lanke J; Hedner T; Niklason A; Luomanmäki K; Dahlöf B; de Faire U; Mörlin C; Karlberg BE; Wester PO; Björck JE
    Lancet; 1999 Feb; 353(9153):611-6. PubMed ID: 10030325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic changes during antihypertensive therapy in the International Prospective Primary Prevention Study in Hypertension.
    Bolli P; Burkart F; Vesanen K; Baker JL; Pinto M; Buhler FR
    Hypertension; 1987 Jun; 9(6 Pt 2):III69-74. PubMed ID: 3596789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
    Hansson L
    J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials.
    Schröder R
    Z Kardiol; 1985; 74 Suppl 6():165-72. PubMed ID: 2869616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.
    Hansson L; Hedner T; Lund-Johansen P; Kjeldsen SE; Lindholm LH; Syvertsen JO; Lanke J; de Faire U; Dahlöf B; Karlberg BE
    Lancet; 2000 Jul; 356(9227):359-65. PubMed ID: 10972367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk-benefit equation: when to initiate treatment.
    Robertson JI
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):181S-185S, 187S. PubMed ID: 6152401
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How to decrease the risk of myocardial infarct in patients with hypertension?].
    Bühler FR
    Cor Vasa; 1988; 30(1):1-10. PubMed ID: 2897894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diuretic agents versus beta-blockers. Comparison of effects on mortality, stroke, and coronary events.
    Furberg CD; Cutler JA
    Hypertension; 1989 May; 13(5 Suppl):I57-61. PubMed ID: 2577460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive therapy and myocardial infarction: focus on calcium antagonists.
    Bühler FR; Müller FB; Linder L; Bolli P
    J Hypertens Suppl; 1985 Nov; 3(2):S95-8. PubMed ID: 2868083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.